TrialAIDS research and human retroviruses2012

A switch in therapy to a reverse transcriptase inhibitor sparing combination of lopinavir/ritonavir and raltegravir in virologically suppressed HIV-infected patients: a pilot randomized trial to assess efficacy and safety profile: the KITE study.

Ighovwerha Ofotokun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.